The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets.

导出 OA

翻译打印收藏纠错

第一作者： Job,van Riet

第一单位： Cancer Computational Biology Center, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.;Department of Urology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.;Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.

作者： Job,van Riet ^[1] ; Harmen J G,van de Werken ^[2] ; Edwin,Cuppen ^[3] ; Ferry A L M,Eskens ^[4] ; Margot,Tesselaar ^[5] ; Linde M,van Veenendaal ^[5] ; Heinz-Josef,Klümpen ^[6] ; Marcus W,Dercksen ^[7] ; Gerlof D,Valk ^[8] ; Martijn P,Lolkema ^[9] ; Stefan,Sleijfer ^[9] ; Bianca,Mostert ^[10]

作者单位： Cancer Computational Biology Center, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.;Department of Urology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.;Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. ^[1] Cancer Computational Biology Center, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands. h.vandewerken@erasmusmc.nl.;Department of Urology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands. h.vandewerken@erasmusmc.nl. ^[2] Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, the Netherlands.;Hartwig Medical Foundation, Amsterdam, the Netherlands. ^[3] Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. ^[4] Department of Medical Oncology, Cancer Institute, University of Amsterdam, Amsterdam, The Netherlands. ^[5] Department of Medical Oncology, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, The Netherlands. ^[6] Department of Internal Medicine, Maxima Medisch Centrum, Veldhoven, The Netherlands. ^[7] Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, The Netherlands. ^[8] Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.;Center for Personalized Cancer Treatment, Rotterdam, the Netherlands. ^[9] Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. b.mostert@erasmusmc.nl. ^[10]